Under the deal, both the firms have agreed to collaborate on the development of bacteriophage (or phage) based technology for a range of applications.
Intralytix CEO John Woloszyn said their phage-based technology is all natural and environmentally friendly and they look forward to this collaboration bringing forth new innovations.
"The company already has two FDA/USDA approved phage-based products on the market: ListShield, effective at substantially reducing or eliminating Listeria monocytogenes on food products, and EcoShield, effective at substantially reducing or eliminating E. coli O157:H7 on red meat intended for grinding," Woloszyn said.